More Cures for More Patients: Overcoming Pharmaceutical Barriers

February 05, 2020

Testimony
Testimony by CFR fellows and experts before Congress.

Mr. Setser's testimony focuses on three points:

1. America currently has a large and growing trade deficit in pharmaceutical products.

More on:

Trade

Pharmaceuticals and Vaccines

Fiscal Policy

2. The Tax Cuts and Jobs Act created new incentives for the offshoring of pharmaceutical production and other high technology manufacturing jobs. As I will discuss later, the biggest sources of pharmaceutical imports are not countries known for low wages, but rather countries known for their high tolerance of transfer pricing games and generous tax treatment of multinational firms.

3. The Tax Cut and Jobs Act provided a large windfall to the shareholders of pharmaceutical firms who had shifted their profits and often production abroad to reduce their U.S. tax burden—but it hasn’t generated lower prices for American consumers or a significant increase in investment in pharmaceutical research and development. The work of the Ways and Means committee staff1 has illustrated that Americans pay by far the world’s highest prices for drugs. Yet today, Americans are getting far too little back from our biggest pharmaceutical companies.

More on:

Trade

Pharmaceuticals and Vaccines

Fiscal Policy

Top Stories on CFR

Economics

The consequences of the COVID-19 pandemic and the rise of China have prompted renewed debate about the U.S. government’s role in shaping the economy.

United States

Progress on President Biden’s climate agenda will slow with a split Congress. But with federal efforts dulled, state-level action could supply added momentum.

International Organizations

The 2022 FIFA World Cup has kicked off in Qatar, and billions of fans worldwide are tuning in to the world’s most popular live event. And yet as in years past, the Qatar Cup is transpiring under the shadow of controversy.